InnoBrain's neurotech platform, based on neuroscience and artificial intelligence, allows manufacturers of medical devices to gather objective and unbiased information from usability evaluations, detecting and preventing usability failures early on. By reducing usability failures to zero, InnoBrain helps companies increase human safety and improve their return on investment (ROI). Founded in 2017 and headquartered in Stockholm, Sweden, InnoBrain offers an innovative BCI platform that enables subjective evaluation of human cognitive and emotional states for industrial use. Their Cognitive Data platform enables human cognitive monitoring at scale, promoting self-cognitive awareness and securing human safety.